Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

First patient dosed in phase II study of AG-10 in ATTR cardiomyopathy

May 4, 2018

Bristol-Myers Squibb presents new apelin receptor agonists

May 4, 2018

Actelion seeks FDA approval of Opsumit for inoperable chronic thromboembolic pulmonary hypertension

May 2, 2018

Enrollment open in phase II study of dutogliptin for early recovery post-myocardial infarction

April 30, 2018

GlaxoSmithKline describes novel TrpV4 antagonists

April 24, 2018

GlaxoSmithKline patents novel TrpV4 antagonists

April 18, 2018

Astellas grants Cardurion license for PDE9 inhibitor with potential in heart failure

April 18, 2018

Phase I/II study of DNA vaccine for hypertension begins in Australia

April 13, 2018

Novel dopamine beta-hydroxylase inhibitors identified at BIAL-Portela & Ca.

April 13, 2018

New TRPV4 antagonists discovered at GlaxoSmithKline

April 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...